Proceeding contribution from Baroness Primarolo (Labour) in the House of Commons on Thursday, 8 May 2008. It occurred during Adjournment debate on National Institute for Health and Clinical Excellence.
National Institute for Health and Clinical Excellence
If the hon. Lady will let me reassure her on one further point, I will happily give way. The basis for the negotiations agreed by both the industry and the Government is that the new agreement must deliver value for money, encourage and reward innovation, assist the uptake of new medicines and provide stability, sustainability and predictability for both the NHS and the industry.
Secondary information
- Type
- Proceeding contribution
- Reference
- 475 c339WH
- Session
- 2007-08
- Chamber / Committee
- Westminster Hall
- Subjects
- Costs Health services Drugs NHS Medical treatments National Institute for Health and Care Excellence Research
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 03:02:33 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_470652
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_470652
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_470652